Top

Gepubliceerd in:

2004 | OriginalPaper | Hoofdstuk

3. Diagnostiek van chronisch hartfalen

Auteur : drs. Frans Rutten

Uitgeverij: Bohn Stafleu van Loghum

Abstract

Diagnostiek is vaak een onderbelicht deel van de geneeskunde. Het is echter een onmisbaar onderdeel. Zeker bij een aandoening als hartfalen is het belangrijk om voldoende zeker te zijn van de diagnose, alvorens men overgaat op behandeling en begeleiding. Daarnaast moet men als behandelaar niet alleen voldoende zeker zijn over de diagnose in geval van hartfalen, maar ook voldoende zeker over de oorzaak ervan. Dit betekent niet dat altijd alle vormen van diagnostiek hoeven te worden gebruikt om als behandelaar ‘100% zeker’ te zijn. Soms vallen om sociaal-medische (zeer hoge leeftijd, hoge immobiliteit), logistieke of financiële argumenten een aantal van de in dit hoofdstuk besproken diagnostische onderzoeken af. Zo is momenteel (Doppler)echocardiografie voor patiënten onder behandeling bij een huisarts of verpleeghuisarts niet zo gemakkelijk toegankelijk omdat een verwijzing naar de cardioloog hiervoor noodzakelijk is en er lange wachtlijsten bestaan voor echocardiografie door een tekort aan echolaboranten. Schoorvoetend komen er ‘open access’-echocardiografiefaciliteiten in Nederland, waardoor de toegankelijkheid voor echocardiografie verhoogd wordt.

vorige hoofdstuk Etiologie en pathofysiologie van hartfalen

volgende hoofdstuk Medicatie bij hartfalen

Nederlandse Vereniging voor Cardiologie en Nederlandse Hartstichting. Multidisciplinaire richtlijn chronisch hartfalen. Alphen aan den Rijn: Van Zuiden Communications bv; oktober 2002. ISBN 90-76906-57-2.

Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. jama 1994, 271: 703–707.CrossRefPubMed

Jaeschke R, Guyatt G, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group, jama 1994, 271: 389–391.CrossRefPubMed

Vasan RS, Levy D. Defïning diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101:2118–2121.CrossRefPubMed

European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998, 19:990–1003.CrossRef

Vasan RS, Levy D, Larson MG, Benjamin EJ. Interpretation of echocardiographic measurements: a call for standardization. Am Heart J 2000, 139:412–422.CrossRefPubMed

Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrillo JE et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002, 112:437–445.CrossRefPubMed

Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from ‘diastolic’ heart failure or from misdiagnosis? A prospective descriptive study. bmj 2000, 321: 215–218.PubMedCentralCrossRefPubMed

Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991, 12:315–321.CrossRefPubMed

10.

Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. Assessing diagnosis in heart failure: which features are any use? qjm 1997, 90: 335–339.CrossRefPubMed

11.

Cost B. Heart Failure in the elderly [Thesis]. Rotterdam: Erasmus Universiteit; 2000.

12.

Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001, 22: 1527–1560.CrossRefPubMed

13.

Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22: 6A-13A.CrossRefPubMed

14.

Messina LM, Zelenock GB, Yao KA, Stanley JC. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J Vasc Surg 1992,15: 73–72.CrossRefPubMed

15.

Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, WexlerJP, Budner N et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988, 77: 607–612.CrossRefPubMed

16.

Remes J, Länsimies E, Pyörälä K. Usefulness of M-mode echocardiography in the diagnosis of heart failure. Cardiology 1991, 78:267–277.CrossRefPubMed

17.

van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992, 70: 359–363.CrossRefPubMed

18.

Gadsboll N, Hoilund-Carlsen PF, Nielsen GG, Berning J, Brunn NE, Stage P et al. Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989, 10: 1017–1028.PubMed

19.

Ishmail AA, Wing S, Ferguson J, Hutchinson TA, Magder S, Flegel KM. Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest 1987, 91: 870–873.CrossRefPubMed

20.

Spiteri MA, Cook DG, Clarke SW. Reliability of eliciting physical signs in examination of the chest. Lancet 1988, 1: 873–875.CrossRefPubMed

21.

Stevenson LW,.Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. jama 1989, 261: 884–888.CrossRefPubMed

22.

Harlan WR, Oberman A, Grimm R, Rosati RA. Chronic congestive heart failure in coronary artery disease: clinical criteria. Ann Intern Med 1977, 86: 133–138.CrossRefPubMed

23.

Echeverria HH, Bilsker MS, Myerburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med 1983,75: 750–755.CrossRefPubMed

24.

Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults? jama 1997, 277: 1712–1719.CrossRefPubMed

25.

Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension.J Am Coll Cardiol 1993, 22: 968–974.CrossRefPubMed

26.

O’Neill TW, Barry M, Smith M, Graham IM. Diagnostic value of the apex beat. Lancet 1989, 1: 410–411.CrossRefPubMed

27.

Mattleman SJ, Hakki AH, Iskandrian AS, Segal BL, Kane SA. Reliability of bedside evaluation in determining left ventricular function: correlation with left ventricular ejection fraction determined by radionuclide ventriculography. J Am Coll Cardiol 1983, 1: 417–420.CrossRefPubMed

28.

Heckerling PS, Wiener SL, Wolfkiel CJ, Kushner MS, Dodin EM, Jelnin V et al. Accuracy and reproducibility of precordial percussion and palpation for detecting increased left ventricular end-diastolic volume and mass. A comparison of physical findings and ultrafast computed tomography of the heart. jama 1993, 270: 1943–1948.CrossRefPubMed

29.

Eilen SD, Crawford MH, O’Rourke RA. Accuracy of precordial palpation for detecting increased left ventricular volume. Ann Intern Med 1983, 99: 628–630.CrossRefPubMed

30.

Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001, 345: 574–581.CrossRefPubMed

31.

Folland ED, Kriegel BJ, Henderson WG, Hammermeister KE, Sethi GK. Implications of third heart sounds in patients with valvular heart disease. The Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med 1992, 327:458–462.CrossRefPubMed

32.

Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996, 156: 146–157.CrossRefPubMed

33.

Smith H, Pickering RM, Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. bmj 2000, 320:906–908.PubMedCentralCrossRefPubMed

34.

McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997, 350: 829–833.CrossRefPubMed

35.

Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997, 350: 1349–1353.CrossRefPubMed

36.

Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002,105: 595–601.CrossRefPubMed

37.

Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002, 39: 131–138.CrossRefPubMed

38.

Anderson JV, Woodruff PW, Bloom SR. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br Heart J 1987, 57: 578–579.

39.

Davis KM, Fish LC, Elahi D, Clark BA, Minaker KL. Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. jama 1992, 267:2625–2629.CrossRefPubMed

40.

Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H, Nicholls MG. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 1993, 69: 414–417.PubMedCentralCrossRefPubMed

41.

Davis M, Espiner E, Richards G, Billings J, Town I, Neill A et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994, 343: 440–444.CrossRefPubMed

42.

Morgan S, Smith H, Simpson I, Liddiard G, Raphael H, Pickering R et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional servey. bmj 2000, 318: 368–372.CrossRef

43.

Nielsen OW, Hansen J, Hilden J, Larsen ST, Svanegaard J. Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. bmj 2000, 320: 220–224.PubMedCentralCrossRefPubMed

44.

Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. bmj 2000, 320: 985–986.PubMedCentralCrossRefPubMed

45.

McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998, 351: 9–13.CrossRefPubMed

46.

Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. bmj 1996, 312: 222.PubMedCentralCrossRefPubMed

47.

Gillespie ND, McNeill G, Pringle T, Ogston S, Struthers AD, Pringle SD. Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea. bmj 1997, 314: 936–940.PubMedCentralCrossRefPubMed

48.

Stapleton JF, Segal JP, Harvey WP. The electrocardiogram of myocardopathy. Prog Cardiovasc Dis 1970, 13: 217–239.CrossRefPubMed

49.

Christian TF, Miller TD, Chareonthaitawee P, Hodge DO, O’Connor MK, Gibbons RJ. Prevalence of normal resting left ventricular function with normal rest electrocardiograms. Am J Cardiol 1997, 79: 1295–1298.CrossRef

50.

Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol 1995, 75: 220–223.CrossRefPubMed

51.

Parameshwar J, Poole-Wilson PA, Sutton GC. Heart failure in a district general hospital. J R Coll Physicians Lond 1992, 26: 139–142.PubMed

52.

Badgett RG, Mulrow CD, Otto PM, Ramirez G. How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med 1996, 11: 625–634.CrossRefPubMed

53.

McNamara RF, Carleen E, Moss AJ. Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. Am J Cardiol 1988, 62: 192–196.CrossRefPubMed

54.

Engler R, Ray R, Higgins CB, McNally C, Buxton WH, Bhargava V et al. Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy. Am J Cardiol 1982, 49: 1832–1837.CrossRefPubMed

55.

McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N EnglJ Med 1971, 285: 1441–1446.CrossRef

56.

Willenheimer RB, Israelsson BA, Cline CM, Erhardt LR. Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J 1997, 31: 9–16.CrossRefPubMed

57.

European Study Group on Diastolic Heart Failure How to diagnose diastolic heart failure. Eur Heart J 1998, 19: 990–1003.

58.

Aguirre FV, Pearson AC, Lewen MK, McCluskey M, Labovitz AJ. Usefulness of Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 1989, 63: 1098–1102.CrossRefPubMed

59.

Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 1999, 20: 447–455.CrossRefPubMed

60.

Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. chs Research Group. Cardiovascular Health Study. Am J Cardiol 2001, 87: 413–419.CrossRefPubMed

61.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The solvd Investigators. N Engl J Med 1991, 325: 293–302.

62.

Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. jama 1994, 271: 1276–1280.CrossRefPubMed

63.

Madsen EB, Gilpin E, Slutsky RA, Ahnve S, Henning H, Ross JJ. Usefulness of the chest x-ray for predicting abnormal left ventricular function after acute myocardial infarction. Am Heart J 1984, 108: 1431–1436.CrossRefPubMed

64.

Plein S, Bloomer TN, Ridgway JP, Jones TR, Bainbridge GJ, Sivananthan MU. Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging 2001, 14:230–236.CrossRefPubMed

65.

Benge W, Litchfield RL, Marcus ML. Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980, 61: 955–959.CrossRefPubMed

66.

Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985, 132: 919–923.PubMedCentralPubMed

67.

Bittner V, Weiner DH, Yusuf S, Rogers WJ, Mclntyre KM, Bangdiwala SI et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. solvd Investigators. jama 1993, 270: 1702–1707.CrossRefPubMed

68.

Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise training in chronic heart failure patients. Eur Heart J 2001, 22: 125–135.

69.

Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995, 92: 3436–3444.CrossRefPubMed

70.

Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998, 79: 281–288.PubMedCentralCrossRefPubMed

71.

Elefteriades JA, Morales DL, Gradel C, Tollis GJ, Levi E, Zaret BL. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%. Am J Cardiol 1997, 79: 1573–1578.CrossRefPubMed

72.

Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344: 563–570.CrossRefPubMed

73.

Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990, 82: 1629–1646.CrossRefPubMed

74.

Becker AE, Heijmans CD, Essed CE. Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra? Eur Heart J 1991, 12: 218–223.PubMed

75.

Bigger JTJ, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984, 69: 250–258.CrossRefPubMed

76.

Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984, 53: 902–907.CrossRefPubMed

77.

Moss AJ, Hall WJ Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335: 1933–1940.CrossRefPubMed

78.

Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999, 341: 1882–1890.CrossRefPubMed

79.

Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb P, Harrington D et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 1997, 96: 2586–2594.CrossRefPubMed

80.

Brouwer J, van-Veldhuisen DJ, Man in ‘t Veld AJ, Dunselman PH, Boomsma F, Haaksma J et al. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. J Am Coll Cardiol 1995, 26: 983–990.CrossRefPubMed

81.

Malik M, Camm AJ. Components of heart rate variability - what they really mean and what we really measure. Am J Cardiol 1993, 72: 821–822.CrossRefPubMed

82.

Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 1992, 67: 482–485.PubMedCentralCrossRefPubMed

83.

van Rugge FP, Holman ER, van der Wall EE, de Roos A, van der Laarse A, Bruschke AV. Quantitation of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J 1993, 14: 456–463.CrossRefPubMed

84.

Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography [zie comments]. Ann Intern Med 1992, 116: 190–196.CrossRefPubMed

85.

Ferrari R, La Canna G, Giubbini R, Visioli O. Stunned and hibernating myocardium: possibility of intervention. J Cardiovasc Pharmacol 1992,20 Suppl 5: S5-S13.CrossRefPubMed

86.

Pierard LA, Lancellotti P, Benoit T. Myocardial viability. Stress echocardiography vs nuclear medicine. Eur Heart J 1997,18 Suppl D: Dl17–D123.CrossRefPubMed

87.

Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease [zie comments]. Circulation 1995, 91: 2556–2565.CrossRefPubMed

88.

Dagianti A, Penco M, Agati L, Sciomer S, Rosanio S, Fedele F. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995, 26: 18–25.CrossRefPubMed

89.

Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur Heart J 1988, 9: 1215–1222.PubMed

90.

McNamara RM, Cionni DJ. Utility of the peak expiratory flow rate in the differentiation of acute dyspnea. Cardiac vs pulmonary origin. Chest 1992, 101: 129–132.PubMed

91.

Kannel WB, Agostino RB, Silbershatz H. Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. Am J Cardiol 1996, 77: 1155–1158.CrossRefPubMed

92.

Prins A, Verheugt FWA, Cardiologie, Houten: BSL; 1998.

Titel: Diagnostiek van chronisch hartfalen
Auteur: drs. Frans Rutten
Uitgeverij: Bohn Stafleu van Loghum
Boek: Zorg rondom hartfalen
Print ISBN: 978-90-313-3769-9

Elektronisch ISBN: 978-90-313-9399-2

Copyright: 2004
DOI: https://doi.org/10.1007/978-90-313-9399-2_3

Bohn Stafleu van Loghum

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Registreer

Login

3. Diagnostiek van chronisch hartfalen

Abstract

Bohn Stafleu van Loghum

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Registreer

Login

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen